查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1771619

脫髮症市場規模、佔有率、趨勢分析報告：按疾病類型、治療方法、性別、銷售管道、最終用途、地區、細分市場預測，2025-2030 年

Alopecia Market Size, Share & Trends Analysis Report By Disease Type (Alopecia Areata, Cicatricial, Traction, Androgenetic Alopecia), By Treatment, By Gender, By Sales Channel, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

脫髮症市場的成長和趨勢：

根據Grand View Research, Inc.的最新報告，全球脫髮症市場預計到2030年將達到160.2億美元，2025年至2030年期間的複合年成長率為8.7%。

JAK抑制劑和蛋白酪氨酸激酶抑制劑的核准以及目標疾病盛行率的上升預計將推動市場成長。

脫髮症(AA) 和頭皮脫髮(脫髮症)的盛行率在全球範圍內呈上升趨勢。根據 2023 年 3 月發表的一篇研究論文，脫髮症占美國和英國皮膚科診所新發病例的 0.6% 至 2%。全球範圍內進行的醫院調查估計，AA 的發生率在 0.57% 至 3.8% 之間。

新型標靶治療藥物的核准是推動脫髮症市場成長的關鍵因素。例如，2022年6月，美國FDA核准了禮來的Olumiant口服錠劑，用於治療成人重度脫髮症，使其成為首個核准的系統性治療藥物。另一個預計在2023年核准的關鍵藥物是輝瑞的利曲替尼，這是一種Janus激酶3（JAK3）和蛋白酪氨酸激酶的雙重抑制劑。

推動該行業成長的另一個關鍵因素是人們對脫髮症的認知不斷提高，以及由此帶來的全球治療率的上升。人們對外觀的意識層級不斷提高是尋求治療的人數增加的主要原因之一。此外，研發和資金籌措的增加也推動了市場的成長。

用於治療潛在疾病的標靶治療藥物供應有限是該市場面臨的主要挑戰之一。雖然具有靶向作用機制的新產品正在核准，但與核准的產品相比，這些藥物的成本較高，這仍然是其廣泛應用的主要障礙之一。

脫髮症市場報告重點

  • 由於輝瑞公司處於預先註冊階段的 Ritlecitinib 和 Bioniz 脫髮症處於第 2 階段研發線產品即將核准，預計斑禿領域將成為 2025 年至 2030 年間成長最快的領域。
  • 2024 年，北美將佔據市場主導地位，這主要歸功於其較高的消費者意識、技術進步、龐大的目標疾病人群以及高昂的醫療保健支出。
  • 預計亞太地區在預測期內將以最高的複合年成長率成長，這主要歸因於疾病目標族群的成長和治療率的上升。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章脫髮症市場變數、趨勢和範圍

  • 市場展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 脫髮症市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
  • 專利到期分析
  • 管道分析
    • 第一階段
    • 第 2 階段
    • 第 3 階段

第4章脫髮症市場：疾病類型估計和趨勢分析

  • 2024 年及 2030 年各疾病類型的市場佔有率
  • 細分儀表板
  • 全球脫髮症市場（按疾病類型）前景
  • 2018年至2030年市場規模、預測及趨勢分析
    • 脫髮症
    • 脫髮症
    • 牽引性脫髮症
    • 全脫髮症
    • 脫髮症
    • 雄性脫髮症
    • 其他

第5章脫髮症市場：治療評估與趨勢分析

  • 2024 年及 2030 年各治療方法市場佔有率
  • 細分儀表板
  • 全球脫髮症市場（治療方法）展望
  • 2018年至2030年市場規模、預測及趨勢分析
    • 製藥
    • 裝置

第6章脫髮症市場：性別估計和趨勢分析

  • 2024 年和 2030 年按性別分類的市場佔有率
  • 細分儀表板
  • 性別：全球脫髮症市場展望
  • 2018年至2030年市場規模、預測及趨勢分析
    • 男性
    • 女士

第7章脫髮症市場：銷售管道評估與趨勢分析

  • 2024年及2030年按銷售管道分類的市場佔有率
  • 細分儀表板
  • 全球脫髮症市場按銷售管道分類的前景
  • 2018年至2030年市場規模、預測及趨勢分析
    • 處方箋
    • 非處方藥

第8章脫髮症市場：最終用途估計和趨勢分析

  • 2024 年和 2030 年按最終用途分類的市場佔有率
  • 細分儀表板
  • 全球脫髮症市場展望（按最終用途）
  • 2018年至2030年市場規模、預測及趨勢分析
    • 居家照護環境
    • 皮膚科診所

第9章脫髮症市場：區域估計和趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 市場規模、預測趨勢分析，2018 年至 2030 年：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章 競爭格局

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • Key company market share analysis, 2024
    • Janssen Global Services Inc.
    • Cipla
    • Merck &Co., Inc.
    • GSK plc
    • Sun Pharmaceuticals Industries Ltd
    • Dr. Reddy's Laboratories Ltd
    • Aurobindo Pharma
    • Viatris Inc.
    • Pfizer, Inc.
    • Eli Lilly and Company
    • Lexington Intl., LLC（Devices）
    • Freedom Laser Therapy（iRestore ID-520 helmet）
    • Curallux, LLC.
    • Apira Science Inc.（iGROW Laser）
    • Revian Inc.
    • Theradome
    • Lutronic
Product Code: 978-1-68038-856-5

Alopecia Market Growth & Trends:

The global alopecia market size is expected to reach USD 16.02 billion by 2030, registering a CAGR of 8.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. The approval of JAK inhibitors and tyrosine kinase inhibitors along with the rising target disease prevalence is expected to drive market growth.

The prevalence of alopecia areata (AA) and alopecia to talis is increasing globally. It is one of the most commonly encountered problems in clinics in the U.S. As per a research article published in March 2023, in the U.S. and UK, AA accounted for 0.6% to 2% of the new cases encountered in dermatology clinics. In hospital-based studies performed worldwide the incidence of AA is estimated to range between 0.57% to 3.8%.

The approval of new targeted pharmaceutical treatments is a key factor driving the alopecia market growth. For instance, in June 2022, the U.S. FDA approved Lilly's Olumiant oral tablets for the treatment of severe alopecia in adult patients and is the first systemic treatment approved. Another key drug that is anticipated to be approved in 2023 is Pfizer's Ritlecitinib. It is a dual inhibitor of Janus kinase 3 (JAK3) and tyrosine kinases.

Another key factor driving the industry's growth is the increasing awareness regarding alopecia and thereby increasing treatment rates worldwide. The increase in the level of consciousness regarding physical appearance is one of the major reasons for the rising number of people seeking treatment. Additionally, rising investments in R&D and funding are also fueling market growth.

The limited availability of targeted drugs that treat the underlying condition is one key challenge for the market. While new products with targeted mechanisms of action are being approved the high cost of these drugs in comparison to the already approved products is one of the major hindrances in their widespread adoption.

Alopecia Market Report Highlights:

  • The alopecia universalis segment is expected to witness the fastest growth from 2025 to 2030, owing to the impending approval of pipeline products, such as Pfizer's Ritlecitinib which is in the pre-registration phase, and Bioniz Therapeutics's BNZ-1 which is in phase 2 clinical trials
  • North America dominated the market in 2024, mainly due to the high consumer awareness, technological advancements, high target disease population, and high healthcare spending
  • Asia Pacific is expected to grow at the highest CAGR during the forecast period. This can be majorly attributed to the rising target disease population and rising treatment rate for the disease.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Disease Type
    • 1.2.2. Treatment
    • 1.2.3. Gender
    • 1.2.4. Sales Channel
    • 1.2.5. End Use
    • 1.2.6. Regional scope
    • 1.2.7. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Disease Type
    • 2.2.2. Treatment
    • 2.2.3. Gender
    • 2.2.4. Sales Channel
    • 2.2.5. End Use
    • 2.2.6. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Alopecia Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing global prevalence of alopecia
      • 3.2.1.2. Increasing global healthcare expenditure
      • 3.2.1.3. Increasing prevalence of chronic diseases
        • 3.2.1.3.1. PCOS
        • 3.2.1.3.2. Cancer
        • 3.2.1.3.3. Rheumatoid Arthritis
      • 3.2.1.4. Technological advancements in alopecia treatment
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of reimbursement policies for alopecia treatment
      • 3.2.2.2. Increasing adoption of substitutes
  • 3.3. Alopecia Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. Patent Expiry Analysis
  • 3.5. Pipeline Analysis
    • 3.5.1. Phase 1
    • 3.5.2. Phase 2
    • 3.5.3. Phase 3

Chapter 4. Alopecia Market: Disease Type Estimates & Trend Analysis

  • 4.1. Disease Type Market Share, 2024 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Alopecia Market by Disease Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Alopecia Areata
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.2. Male
        • 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.3. Female
        • 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Cicatricial Alopecia
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.2. Male
        • 4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.3. Female
        • 4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Traction Alopecia
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.2. Male
        • 4.4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.3. Female
        • 4.4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Alopecia Totalis
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.4.2. Male
        • 4.4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.4.3. Female
        • 4.4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Alopecia Universalis
      • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.5.2. Male
        • 4.4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.5.3. Female
        • 4.4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.6. Androgenetic Alopecia
      • 4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.6.2. Male
        • 4.4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.6.3. Female
        • 4.4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.7. Others
      • 4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.7.2. Male
        • 4.4.7.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.7.3. Female
        • 4.4.7.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Alopecia Market: Treatment Estimates & Trend Analysis

  • 5.1. Treatment Market Share, 2024 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Alopecia Market by Treatment Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Pharmaceuticals
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.4.1.2. Topical
        • 5.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
        • 5.4.1.2.2. OTC
          • 5.4.1.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
          • 5.4.1.2.2.2. Minoxidil
            • 5.4.1.2.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
          • 5.4.1.2.2.3. Others
            • 5.4.1.2.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
        • 5.4.1.2.3. Prescription
          • 5.4.1.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
          • 5.4.1.2.3.2. Betamethasone Dipropionate
            • 5.4.1.2.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
          • 5.4.1.2.3.3. Fluocinolone Acetonide
            • 5.4.1.2.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
          • 5.4.1.2.3.4. Finasteride
            • 5.4.1.2.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
          • 5.4.1.2.3.5. Minoxidil
            • 5.4.1.2.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.4.1.3. Oral
        • 5.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
        • 5.4.1.3.2. OTC
          • 5.4.1.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
        • 5.4.1.3.3. Prescription
          • 5.4.1.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
          • 5.4.1.3.3.2. Minoxidil
            • 5.4.1.3.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
          • 5.4.1.3.3.3. Finasteride
            • 5.4.1.3.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
          • 5.4.1.3.3.4. Corticosteroids
            • 5.4.1.3.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
          • 5.4.1.3.3.5. Others (JAK inhibitors and others)
            • 5.4.1.3.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.4.1.4. PRP
        • 5.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Devices
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.4.2.2. Laser Cap
        • 5.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
        • 5.4.2.2.2. Laser Comb
        • 5.4.2.2.3. Market estimates and forecasts 2018 to 2030 (USD Million)
        • 5.4.2.2.4. Laser Helmet
        • 5.4.2.2.5. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Alopecia Market: Gender Estimates & Trend Analysis

  • 6.1. Gender Market Share, 2024 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Alopecia Market by Gender Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Male
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Female
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Alopecia Market: Sales Channel Estimates & Trend Analysis

  • 7.1. Sales Channel Market Share, 2024 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Alopecia Market by Gender Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.4.1. Prescription
      • 7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. OTC
      • 7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Alopecia Market: End Use Estimates & Trend Analysis

  • 8.1. End Use Market Share, 2024 & 2030
  • 8.2. Segment Dashboard
  • 8.3. Global Alopecia Market by End Use Outlook
  • 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 8.4.1. Homecare Settings
      • 8.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. Dermatology Clinics
      • 8.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Alopecia Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Share Analysis, 2024 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Global Regional Market Snapshot
  • 9.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 9.5. North America
    • 9.5.1. U.S.
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Regulatory framework/ reimbursement structure
      • 9.5.1.3. Competitive scenario
      • 9.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.2. Canada
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework/ reimbursement structure
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.3. Mexico
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework/ reimbursement structure
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6. Europe
    • 9.6.1. UK
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Regulatory framework/ reimbursement structure
      • 9.6.1.3. Competitive scenario
      • 9.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.2. Germany
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework/ reimbursement structure
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.3. France
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Regulatory framework/ reimbursement structure
      • 9.6.3.3. Competitive scenario
      • 9.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.4. Italy
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Regulatory framework/ reimbursement structure
      • 9.6.4.3. Competitive scenario
      • 9.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.5. Spain
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Regulatory framework/ reimbursement structure
      • 9.6.5.3. Competitive scenario
      • 9.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.6. Norway
      • 9.6.6.1. Key country dynamics
      • 9.6.6.2. Regulatory framework/ reimbursement structure
      • 9.6.6.3. Competitive scenario
      • 9.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.7. Sweden
      • 9.6.7.1. Key country dynamics
      • 9.6.7.2. Regulatory framework/ reimbursement structure
      • 9.6.7.3. Competitive scenario
      • 9.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.8. Denmark
      • 9.6.8.1. Key country dynamics
      • 9.6.8.2. Regulatory framework/ reimbursement structure
      • 9.6.8.3. Competitive scenario
      • 9.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7. Asia Pacific
    • 9.7.1. Japan
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Regulatory framework/ reimbursement structure
      • 9.7.1.3. Competitive scenario
      • 9.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.2. China
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework/ reimbursement structure
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.3. India
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework/ reimbursement structure
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.4. Australia
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Regulatory framework/ reimbursement structure
      • 9.7.4.3. Competitive scenario
      • 9.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.5. South Korea
      • 9.7.5.1. Key country dynamics
      • 9.7.5.2. Regulatory framework/ reimbursement structure
      • 9.7.5.3. Competitive scenario
      • 9.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.6. Thailand
      • 9.7.6.1. Key country dynamics
      • 9.7.6.2. Regulatory framework/ reimbursement structure
      • 9.7.6.3. Competitive scenario
      • 9.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8. Latin America
    • 9.8.1. Brazil
      • 9.8.1.1. Key country dynamics
      • 9.8.1.2. Regulatory framework/ reimbursement structure
      • 9.8.1.3. Competitive scenario
      • 9.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.2. Argentina
      • 9.8.2.1. Key country dynamics
      • 9.8.2.2. Regulatory framework/ reimbursement structure
      • 9.8.2.3. Competitive scenario
      • 9.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9. MEA
    • 9.9.1. South Africa
      • 9.9.1.1. Key country dynamics
      • 9.9.1.2. Regulatory framework/ reimbursement structure
      • 9.9.1.3. Competitive scenario
      • 9.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.9.2. Saudi Arabia
      • 9.9.2.1. Key country dynamics
      • 9.9.2.2. Regulatory framework/ reimbursement structure
      • 9.9.2.3. Competitive scenario
      • 9.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.9.3. UAE
      • 9.9.3.1. Key country dynamics
      • 9.9.3.2. Regulatory framework/ reimbursement structure
      • 9.9.3.3. Competitive scenario
      • 9.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.9.4. Kuwait
      • 9.9.4.1. Key country dynamics
      • 9.9.4.2. Regulatory framework/ reimbursement structure
      • 9.9.4.3. Competitive scenario
      • 9.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Company/Competition Categorization
  • 10.3. Vendor Landscape
    • 10.3.1. Key company market share analysis, 2024
    • 10.3.2. Janssen Global Services Inc.
      • 10.3.2.1. Company overview
      • 10.3.2.2. Financial performance
      • 10.3.2.3. Product benchmarking
      • 10.3.2.4. Strategic initiatives
    • 10.3.3. Cipla
      • 10.3.3.1. Company overview
      • 10.3.3.2. Financial performance
      • 10.3.3.3. Product benchmarking
      • 10.3.3.4. Strategic initiatives
    • 10.3.4. Merck & Co., Inc.
      • 10.3.4.1. Company overview
      • 10.3.4.2. Financial performance
      • 10.3.4.3. Product benchmarking
      • 10.3.4.4. Strategic initiatives
    • 10.3.5. GSK plc
      • 10.3.5.1. Company overview
      • 10.3.5.2. Financial performance
      • 10.3.5.3. Product benchmarking
      • 10.3.5.4. Strategic initiatives
    • 10.3.6. Sun Pharmaceuticals Industries Ltd
      • 10.3.6.1. Company overview
      • 10.3.6.2. Financial performance
      • 10.3.6.3. Product benchmarking
      • 10.3.6.4. Strategic initiatives
    • 10.3.7. Dr. Reddy's Laboratories Ltd
      • 10.3.7.1. Company overview
      • 10.3.7.2. Financial performance
      • 10.3.7.3. Product benchmarking
      • 10.3.7.4. Strategic initiatives
    • 10.3.8. Aurobindo Pharma
      • 10.3.8.1. Company overview
      • 10.3.8.2. Financial performance
      • 10.3.8.3. Product benchmarking
      • 10.3.8.4. Strategic initiatives
    • 10.3.9. Viatris Inc.
      • 10.3.9.1. Company overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Product benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10. Pfizer, Inc.
      • 10.3.10.1. Company overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Product benchmarking
      • 10.3.10.4. Strategic initiatives
    • 10.3.11. Eli Lilly and Company
      • 10.3.11.1. Company overview
      • 10.3.11.2. Financial performance
      • 10.3.11.3. Product benchmarking
      • 10.3.11.4. Strategic initiatives
    • 10.3.12. Lexington Intl., LLC (Devices)
      • 10.3.12.1. Company overview
      • 10.3.12.2. Financial performance
      • 10.3.12.3. Product benchmarking
      • 10.3.12.4. Strategic initiatives
    • 10.3.13. Freedom Laser Therapy (iRestore ID-520 helmet)
      • 10.3.13.1. Company overview
      • 10.3.13.2. Financial performance
      • 10.3.13.3. Product benchmarking
      • 10.3.13.4. Strategic initiatives
    • 10.3.14. Curallux, LLC.
      • 10.3.14.1. Company overview
      • 10.3.14.2. Financial performance
      • 10.3.14.3. Product benchmarking
      • 10.3.14.4. Strategic initiatives
    • 10.3.15. Apira Science Inc. (iGROW Laser)
      • 10.3.15.1. Company overview
      • 10.3.15.2. Financial performance
      • 10.3.15.3. Product benchmarking
      • 10.3.15.4. Strategic initiatives
    • 10.3.16. Revian Inc.
      • 10.3.16.1. Company overview
      • 10.3.16.2. Financial performance
      • 10.3.16.3. Product benchmarking
      • 10.3.16.4. Strategic initiatives
    • 10.3.17. Theradome
      • 10.3.17.1. Company overview
      • 10.3.17.2. Financial performance
      • 10.3.17.3. Product benchmarking
      • 10.3.17.4. Strategic initiatives
    • 10.3.18. Lutronic
      • 10.3.18.1. Company overview
      • 10.3.18.2. Financial performance
      • 10.3.18.3. Product benchmarking
      • 10.3.18.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America alopecia market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America alopecia market, by disease type, 2018 - 2030 (USD Million)
  • Table 4 North America alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 5 North America alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 6 North America alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 7 North America alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 8 U.S. alopecia market, by disease type, 2018 - 2030 (USD Million)
  • Table 9 U.S. alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 10 U.S. alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 11 U.S. alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 12 U.S. alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada alopecia market, by disease type, 2018 - 2030 (USD Million)
  • Table 14 Canada alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 15 Canada alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 16 Canada alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 17 Canada alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Mexico alopecia market, by disease type, 2018 - 2030 (USD Million)
  • Table 19 Mexico alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 20 Mexico alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 21 Mexico alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 22 Mexico alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Europe alopecia market, by region, 2018 - 2030 (USD Million)
  • Table 24 Europe alopecia market, by disease type, 2018 - 2030 (USD Million)
  • Table 25 Europe alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 26 Europe alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 27 Europe alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 28 Europe alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Germany alopecia market, by disease type, 2018 - 2030 (USD Million)
  • Table 30 Germany alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 31 Germany alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 32 Germany alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 33 Germany alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 34 UK alopecia market, by disease type, 2018 - 2030 (USD Million)
  • Table 35 UK alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 36 UK alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 37 UK alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 38 UK alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 39 France alopecia market, by disease type, 2018 - 2030 (USD Million)
  • Table 40 France alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 41 France alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 42 France alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 43 France alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Italy alopecia market, by disease type, 2018 - 2030 (USD Million)
  • Table 45 Italy alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 46 Italy alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 47 Italy alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 48 Italy alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Spain alopecia market, by disease type, 2018 - 2030 (USD Million)
  • Table 50 Spain alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 51 Spain alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 52 Spain alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 53 Spain alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Denmark alopecia market, by disease type, 2018 - 2030 (USD Million)
  • Table 55 Denmark alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 56 Denmark alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 57 Denmark alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 58 Denmark alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Sweden alopecia market, by disease type, 2018 - 2030 (USD Million)
  • Table 60 Sweden alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 61 Sweden alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 62 Sweden alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 63 Sweden alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 64 Norway alopecia market, by disease type, 2018 - 2030 (USD Million)
  • Table 65 Norway alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 66 Norway alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 67 Norway alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 68 Norway alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Asia Pacific alopecia market, by region, 2018 - 2030 (USD Million)
  • Table 70 Asia Pacific alopecia market, by disease type, 2018 - 2030 (USD Million)
  • Table 71 Asia Pacific alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 72 Asia Pacific alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 73 Asia Pacific alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 74 Asia Pacific alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 75 China alopecia market, by disease type, 2018 - 2030 (USD Million)
  • Table 76 China alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 77 China alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 78 China alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 79 China alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 80 Japan alopecia market, by disease type, 2018 - 2030 (USD Million)
  • Table 81 Japan alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 82 Japan alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 83 Japan alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 84 Japan alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 85 India alopecia market, by disease type, 2018 - 2030 (USD Million)
  • Table 86 India alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 87 India alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 88 India alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 89 India alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 90 South Korea alopecia market, by disease type, 2018 - 2030 (USD Million)
  • Table 91 South Korea alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 92 South Korea alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 93 South Korea alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 94 South Korea alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 95 Australia alopecia market, by disease type, 2018 - 2030 (USD Million)
  • Table 96 Australia alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 97 Australia alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 98 Australia alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 99 Australia alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 100 Thailand alopecia market, by disease type, 2018 - 2030 (USD Million)
  • Table 101 Thailand alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 102 Thailand alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 103 Thailand alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 104 Thailand alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 105 Latin America alopecia market, by disease type, 2018 - 2030 (USD Million)
  • Table 106 Latin America alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 107 Latin America alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 108 Latin America alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 109 Latin America alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 110 Brazil alopecia market, by disease type, 2018 - 2030 (USD Million)
  • Table 111 Brazil alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 112 Brazil alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 113 Brazil alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 114 Brazil alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 115 Argentina alopecia market, by disease type, 2018 - 2030 (USD Million)
  • Table 116 Argentina alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 117 Argentina alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 118 Argentina alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 119 Argentina alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 120 MEA alopecia market, by region, 2018 - 2030 (USD Million)
  • Table 121 MEA alopecia market, by disease type, 2018 - 2030 (USD Million)
  • Table 122 MEA alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 123 MEA alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 124 MEA alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 125 MEA alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 126 South Africa alopecia market, by disease type, 2018 - 2030 (USD Million)
  • Table 127 South Africa alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 128 South Africa alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 129 South Africa alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 130 South Africa alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 131 Saudi Arabia alopecia market, by disease type, 2018 - 2030 (USD Million)
  • Table 132 Saudi Arabia alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 133 Saudi Arabia alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 134 Saudi Arabia alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 135 Saudi Arabia alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 136 UAE alopecia market, by disease type, 2018 - 2030 (USD Million)
  • Table 137 UAE alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 138 UAE alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 139 UAE alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 140 UAE alopecia market, by end use, 2018 - 2030 (USD Million)
  • Table 141 Kuwait alopecia market, by disease type, 2018 - 2030 (USD Million)
  • Table 142 Kuwait alopecia market, by treatment, 2018 - 2030 (USD Million)
  • Table 143 Kuwait alopecia market, by gender, 2018 - 2030 (USD Million)
  • Table 144 Kuwait alopecia market, by sales channel, 2018 - 2030 (USD Million)
  • Table 145 Kuwait alopecia market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Alopecia market: market outlook
  • Fig. 14 Alopecia competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Alopecia market driver impact
  • Fig. 20 Alopecia market restraint impact
  • Fig. 21 Alopecia market strategic initiatives analysis
  • Fig. 22 Alopecia market: Disease type movement analysis
  • Fig. 23 Alopecia market: Disease type outlook and key takeaways
  • Fig. 24 Alopecia areata market estimates and forecast, 2018 - 2030
  • Fig. 25 Male alopecia areata market estimates and forecast, 2018 - 2030
  • Fig. 26 Female alopecia areata market estimates and forecast, 2018 - 2030
  • Fig. 27 Cicatricial alopecia market estimates and forecast, 2018 - 2030
  • Fig. 28 Male cicatricial alopecia market estimates and forecast, 2018 - 2030
  • Fig. 29 Female cicatricial alopecia market estimates and forecast, 2018 - 2030
  • Fig. 30 Traction alopecia market estimates and forecast, 2018 - 2030
  • Fig. 31 Male traction market estimates and forecast, 2018 - 2030
  • Fig. 32 Female traction market estimates and forecast, 2018 - 2030
  • Fig. 33 Alopecia totalis market estimates and forecast, 2018 - 2030
  • Fig. 34 Male alopecia totalis market estimates and forecast, 2018 - 2030
  • Fig. 35 Female alopecia totalis market estimates and forecast, 2018 - 2030
  • Fig. 36 Alopecia universalis market estimates and forecast, 2018 - 2030
  • Fig. 37 Male alopecia universalis market estimates and forecast, 2018 - 2030
  • Fig. 38 Female alopecia universalis market estimates and forecast, 2018 - 2030
  • Fig. 39 Androgenetic alopecia market estimates and forecast, 2018 - 2030
  • Fig. 40 Male androgenetic alopecia market estimates and forecast, 2018 - 2030
  • Fig. 41 Female androgenetic alopecia market estimates and forecast, 2018 - 2030
  • Fig. 42 Other alopecia market estimates and forecast, 2018 - 2030
  • Fig. 43 Male other alopecia market estimates and forecast, 2018 - 2030
  • Fig. 44 Female other alopecia market estimates and forecast, 2018 - 2030
  • Fig. 45 Alopecia Market: Treatment movement Analysis
  • Fig. 46 Alopecia market: Treatment outlook and key takeaways
  • Fig. 47 Pharmaceuticals market estimates and forecasts, 2018 - 2030
  • Fig. 48 Topical market estimates and forecasts, 2018 - 2030
  • Fig. 49 Topical OTC pharmaceuticals market estimates and forecasts, 2018 - 2030
  • Fig. 50 Topical OTC minoxidil market estimates and forecasts, 2018 - 2030
  • Fig. 51 Topical OTC others market estimates and forecasts, 2018 - 2030
  • Fig. 52 Topical prescription pharmaceuticals market estimates and forecasts, 2018 - 2030
  • Fig. 53 Topical prescription betamethasone dipropionate market estimates and forecasts, 2018 - 2030
  • Fig. 54 Topical prescription fluocinolone acetonide market estimates and forecasts, 2018 - 2030
  • Fig. 55 Topical prescription finasteride market estimates and forecasts, 2018 - 2030
  • Fig. 56 Topical prescription minoxidil market estimates and forecasts, 2018 - 2030
  • Fig. 57 Oral pharmaceuticals market estimates and forecasts, 2018 - 2030
  • Fig. 58 Oral OTC pharmaceuticals market estimates and forecasts, 2018 - 2030
  • Fig. 59 Oral prescription pharmaceuticals market estimates and forecasts, 2018 - 2030
  • Fig. 60 Oral prescription minoxidil market estimates and forecasts, 2018 - 2030
  • Fig. 61 Oral prescription finasteride market estimates and forecasts, 2018 - 2030
  • Fig. 62 Oral prescription corticosteroids market estimates and forecasts, 2018 - 2030
  • Fig. 63 Oral prescription others (JAK inhibitors and others) market estimates and forecasts, 2018 - 2030
  • Fig. 64 PRP market estimates and forecasts, 2018 - 2030
  • Fig. 65 Devices market estimates and forecasts, 2018 - 2030
  • Fig. 66 Laser cap market estimates and forecasts, 2018 - 2030
  • Fig. 67 Laser comb market estimates and forecasts, 2018 - 2030
  • Fig. 68 Laser helmet market estimates and forecasts, 2018 - 2030
  • Fig. 69 Alopecia market: Gender movement analysis
  • Fig. 70 Alopecia market: Gender outlook and key takeaways
  • Fig. 71 Male market estimates and forecasts, 2018 - 2030
  • Fig. 72 Female market estimates and forecasts, 2018 - 2030
  • Fig. 73 Alopecia market: Sales channel movement analysis
  • Fig. 74 Alopecia market: Sales channel outlook and key takeaways
  • Fig. 75 Prescriptions market estimates and forecasts, 2018 - 2030
  • Fig. 76 OTC market estimates and forecasts, 2018 - 2030
  • Fig. 77 Alopecia market: End use movement analysis
  • Fig. 78 Alopecia market: End use outlook and key takeaways
  • Fig. 79 Homecare settings market estimates and forecasts, 2018 - 2030
  • Fig. 80 Dermatology clinics market estimates and forecasts, 2018 - 2030
  • Fig. 81 Global alopecia market: Regional movement analysis
  • Fig. 82 Global alopecia market: Regional outlook and key takeaways
  • Fig. 83 North America
  • Fig. 84 North America market estimates and forecasts, 2018 - 2030
  • Fig. 85 U.S.
  • Fig. 86 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 87 Canada
  • Fig. 88 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 89 Mexico
  • Fig. 90 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 91 Europe
  • Fig. 92 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 93 UK
  • Fig. 94 UK market estimates and forecasts, 2018 - 2030
  • Fig. 95 Germany
  • Fig. 96 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 97 France
  • Fig. 98 France market estimates and forecasts, 2018 - 2030
  • Fig. 99 Italy
  • Fig. 100 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 101 Spain
  • Fig. 102 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 103 Denmark
  • Fig. 104 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 105 Sweden
  • Fig. 106 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 107 Norway
  • Fig. 108 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 109 Asia Pacific
  • Fig. 110 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 111 China
  • Fig. 112 China market estimates and forecasts, 2018 - 2030
  • Fig. 113 Japan
  • Fig. 114 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 115 India
  • Fig. 116 India market estimates and forecasts, 2018 - 2030
  • Fig. 117 Thailand
  • Fig. 118 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 119 South Korea
  • Fig. 120 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 121 Australia
  • Fig. 122 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 123 Latin America
  • Fig. 124 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 125 Brazil
  • Fig. 126 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 127 Argentina
  • Fig. 128 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 129 Middle East and Africa
  • Fig. 130 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 131 South Africa
  • Fig. 132 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 133 Saudi Arabia
  • Fig. 134 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 135 UAE
  • Fig. 136 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 137 Kuwait
  • Fig. 138 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 139 Market share of key market players- Alopecia market